Mismatch negativity generation in the human 5HT(2A) agonist and NMDA antagonist model of psychosis

RATIONALE: Many studies have reported deficits of mismatch negativity (MMN) in schizophrenic patients. Pharmacological challenges with hallucinogens in healthy humans are used as models for psychotic states. Previous studies reported a significant reduction of MMN after ketamine (N-methyl-d-aspartat...

Descripción completa

Detalles Bibliográficos
Autores principales: Heekeren, Karsten, Daumann, Jörg, Neukirch, Anna, Stock, Carsten, Kawohl, Wolfram, Norra, Christine, Waberski, Till D., Gouzoulis-Mayfrank, Euphrosyne
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668652/
https://www.ncbi.nlm.nih.gov/pubmed/18488201
http://dx.doi.org/10.1007/s00213-008-1129-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668652/
https://www.ncbi.nlm.nih.gov/pubmed/18488201
http://dx.doi.org/10.1007/s00213-008-1129-4

Ejemplares similares